B of A Securities analyst Joshua Dennerlein upgrades Americold Realty Trust (NYSE:COLD) from Underperform to Neutral and raises the price target from $28 to $30.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.